USA - NASDAQ:AHI - US00777C2035 - ADR
The current stock price of AHI is 1.5 USD. In the past month the price decreased by -29.29%. In the past year, price increased by 195.39%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 36.74 | 44.87B | ||
| DOCS | DOXIMITY INC-CLASS A | 28.91 | 8.88B | ||
| WAY | WAYSTAR HOLDING CORP | 26.02 | 6.66B | ||
| HTFL | HEARTFLOW INC | N/A | 2.28B | ||
| CERT | CERTARA INC | 16.26 | 1.31B | ||
| SDGR | SCHRODINGER INC | N/A | 1.25B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.24B | ||
| PHR | PHREESIA INC | N/A | 1.17B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.06B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 625.25 | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.97 | 969.39M | ||
| HSTM | HEALTHSTREAM INC | 35.74 | 720.25M |
Advanced Health Intelligence Ltd. engages in the development of a global digital health solution. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-08-17. The Company’s products include Biometric Health Assessment (BHA), FaceScan, and BodyScan. Its BHA delivers preventative healthcare measures and refines risk stratification across populations. Its comprehensive insights cover a range of health vitals and risk predictions, allowing its partners to guide individuals into personalized stepped-care pathways. This includes connecting high-risk individuals to traditional primary care, telehealth, or e-health programs. FaceScan estimates vital signs and predicts the risk of chronic disease on a smartphone or Web browser. FaceScan provides estimated readings on heart rate, respiration rate, blood pressure and more in 30 seconds or less. BodyScan is optimized to run on-device using only a smartphone, to deliver accurate body dimension and composition estimates in 60 seconds or less.
ADVANCED HEALTH INTELLIGENCE
Unit 5, 71-73 South Perth Esplanade
Perth WESTERN AUSTRALIA AU
Employees: 0
Advanced Health Intelligence Ltd. engages in the development of a global digital health solution. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-08-17. The Company’s products include Biometric Health Assessment (BHA), FaceScan, and BodyScan. Its BHA delivers preventative healthcare measures and refines risk stratification across populations. Its comprehensive insights cover a range of health vitals and risk predictions, allowing its partners to guide individuals into personalized stepped-care pathways. This includes connecting high-risk individuals to traditional primary care, telehealth, or e-health programs. FaceScan estimates vital signs and predicts the risk of chronic disease on a smartphone or Web browser. FaceScan provides estimated readings on heart rate, respiration rate, blood pressure and more in 30 seconds or less. BodyScan is optimized to run on-device using only a smartphone, to deliver accurate body dimension and composition estimates in 60 seconds or less.
The current stock price of AHI is 1.5 USD. The price decreased by -2.55% in the last trading session.
AHI does not pay a dividend.
AHI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
AHI stock is listed on the Nasdaq exchange.
ADVANCED HEALTH INTELLIGENCE (AHI) has a market capitalization of 11.66M USD. This makes AHI a Nano Cap stock.
ADVANCED HEALTH INTELLIGENCE (AHI) will report earnings on 2024-02-28.
ChartMill assigns a technical rating of 2 / 10 to AHI. When comparing the yearly performance of all stocks, AHI is one of the better performing stocks in the market, outperforming 97.22% of all stocks.
Over the last trailing twelve months AHI reported a non-GAAP Earnings per Share(EPS) of -1.17. The EPS increased by 55.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -144.01% | ||
| ROE | -632.54% | ||
| Debt/Equity | 0.86 |